Arcellx (ACLX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ACLX Arcellx

Watchlist

59.050
+6.470+12.31%

Close Aug 9 16:00 ET

59.050
0.0000.00%

Post 20:01 ET

3.17BMarket Cap-56778P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Calculating The Intrinsic Value Of Arcellx, Inc. (NASDAQ:ACLX)
Simply Wall StAug 10 08:25 ET
Express News | Arcellx Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
BenzingaAug 9 10:06 ET
Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)
TipRanksAug 9 09:51 ET · Ratings
Piper Sandler Issues a Buy Rating on Arcellx Inc (ACLX)
TipRanksAug 9 08:49 ET · Ratings
Express News | Needham Reiterates Buy on Arcellx, Maintains $81 Price Target
BenzingaAug 9 08:31 ET
Arcellx Analyst Ratings
BenzingaAug 9 08:29 ET · Ratings

Comments

Meltyy

May 16 01:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

NASSER09

Apr 19 13:17

$Arcellx (ACLX.US)$ sell
$Mingteng International (MTEN.US)$ buy

Meltyy

Apr 2 22:13

Gear up for AACR24!

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx (ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics (ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics (BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals (CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals (DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics (FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals (FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

淡定的惠特莫爾

Nov 21, 2023 12:14

The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics

$Direxion Daily S&P Biotech Bull 3x Shares ETF (LABU.US)$

Moomoo AI

Nov 18, 2023 06:40

The analyst community exhibits a heightened bullish sentiment about Arcellx following substantial upgrades in next year's revenue and loss forecasts. Although the company's revenue growth is projected to decelerate, it's still anticipated to outpace the industry growth.